These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 422332)

  • 1. Rod sensitivity relative to cone sensitivity in retinitis pigmentosa.
    Massof RW; Finkelstein D
    Invest Ophthalmol Vis Sci; 1979 Mar; 18(3):263-72. PubMed ID: 422332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between rod perimetric thresholds and full-field rod ERGs in retinitis pigmentosa.
    Birch DG; Herman WK; deFaller JM; Disbrow DT; Birch EE
    Invest Ophthalmol Vis Sci; 1987 Jun; 28(6):954-65. PubMed ID: 3583634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-linked retinitis pigmentosa: functional phenotype of an RP2 genotype.
    Jacobson SG; Roman AJ; Cideciyan AV; Robey MG; Iwata T; Inana G
    Invest Ophthalmol Vis Sci; 1992 Dec; 33(13):3481-92. PubMed ID: 1464493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rod visual fields in cone-rod degeneration. Comparisons to retinitis pigmentosa.
    Birch DG; Anderson JL
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2288-99. PubMed ID: 2242994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy.
    Birch DG; Anderson JL; Fish GE
    Ophthalmology; 1999 Feb; 106(2):258-68. PubMed ID: 9951474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique characteristics of two types of retinitis pigmentosa patients with different rod sensitivities.
    Takahashi H; Miyake Y; Horiguchi M; Tomida N; Takakuwa H
    Jpn J Ophthalmol; 2005; 49(2):114-20. PubMed ID: 15838727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease expression in X-linked retinitis pigmentosa caused by a putative null mutation in the RPGR gene.
    Jacobson SG; Buraczynska M; Milam AH; Chen C; Järvaläinen M; Fujita R; Wu W; Huang Y; Cideciyan AV; Swaroop A
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):1983-97. PubMed ID: 9331262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying rod photoreceptor-mediated vision in retinal degenerations: dark-adapted thresholds as outcome measures.
    Roman AJ; Schwartz SB; Aleman TS; Cideciyan AV; Chico JD; Windsor EA; Gardner LM; Ying GS; Smilko EE; Maguire MG; Jacobson SG
    Exp Eye Res; 2005 Feb; 80(2):259-72. PubMed ID: 15670804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentric retinitis pigmentosa: clinicopathologic correlations.
    Milam AH; De Castro EB; Smith JE; Tang WX; John SK; Gorin MB; Stone EM; Aguirre GD; Jacobson SG
    Exp Eye Res; 2001 Oct; 73(4):493-508. PubMed ID: 11825021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two types of visual dysfunction in autosomal dominant retinitis pigmentosa.
    Kemp CM; Jacobson SG; Faulkner DJ
    Invest Ophthalmol Vis Sci; 1988 Aug; 29(8):1235-41. PubMed ID: 3417410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rod ERGs in retinitis pigmentosa and cone-rod degeneration.
    Birch DG; Fish GE
    Invest Ophthalmol Vis Sci; 1987 Jan; 28(1):140-50. PubMed ID: 3804644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RP cone-rod degeneration.
    Heckenlively JR
    Trans Am Ophthalmol Soc; 1987; 85():438-70. PubMed ID: 3447340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal central retinal function and structure preserved in retinitis pigmentosa.
    Jacobson SG; Roman AJ; Aleman TS; Sumaroka A; Herrera W; Windsor EA; Atkinson LA; Schwartz SB; Steinberg JD; Cideciyan AV
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1079-85. PubMed ID: 19797198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperoxia, hyperglycemia, and photoreceptor sensitivity in normal and diabetic subjects.
    Kurtenbach A; Mayser HM; Jägle H; Fritsche A; Zrenner E
    Vis Neurosci; 2006; 23(3-4):651-61. PubMed ID: 16962009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal foveal spectral sensitivity in retinitis pigmentosa.
    Alexander KR; Hutman LP; Fishman GA
    Invest Ophthalmol Vis Sci; 1987 Apr; 28(4):725-30. PubMed ID: 3557876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local cone and rod system function in patients with retinitis pigmentosa.
    Holopigian K; Seiple W; Greenstein VC; Hood DC; Carr RE
    Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):779-88. PubMed ID: 11222541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autosomal dominant retinitis pigmentosa caused by the threonine-17-methionine rhodopsin mutation: retinal histopathology and immunocytochemistry.
    Li ZY; Jacobson SG; Milam AH
    Exp Eye Res; 1994 Apr; 58(4):397-408. PubMed ID: 7925677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rod-cone interactions in night-blinding disease.
    Arden GB
    Jpn J Ophthalmol; 1987; 31(1):6-19. PubMed ID: 3498067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vision threshold profiles in X-linked retinitis pigmentosa.
    Massof RW; Finkelstein D
    Invest Ophthalmol Vis Sci; 1979 Apr; 18(4):426-9. PubMed ID: 311766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rod phototransduction in retinitis pigmentosa. Distinguishing alternative mechanisms of degeneration.
    Shady S; Hood DC; Birch DG
    Invest Ophthalmol Vis Sci; 1995 May; 36(6):1027-37. PubMed ID: 7730012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.